You just read:

DelMar Pharmaceuticals Announces Accelerated Patient Enrollment of Phase 2 Trial in MGMT-unmethylated Recurrent GBM

News provided by

DelMar Pharmaceuticals, Inc.

Jun 26, 2018, 06:00 ET